Paul E. Freiman is Director at PENWEST PHARMACEUTICALS CO (PPCO). They have made 7 open-market trades across 2 companies since 2006, most recently 2009-09-03.
CIK 0001184160
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2007, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PPCO | SELL | 2009-09-03 | 2009-09-16 | $2.35 | $8K | N/A | N/A | N/A |
| NTII | SELL | 2008-12-10 | 2009-02-12 | $0.51 | $1K | N/A | N/A | N/A |
| PPCO | SELL | 2008-06-10 | 2008-06-12 | $3.09 | $15K | N/A | N/A | N/A |
| PPCO | SELL | 2008-05-12 | 2008-05-23 | $2.64 | $11K | N/A | N/A | N/A |
| NTII | BUY | 2007-12-03 | 2007-12-05 | $3.30 | $10K | N/A | N/A | N/A |
| NTII | SELL | 2007-02-21 | 2007-02-23 | $2.65 | $265K | N/A | N/A | N/A |
| PPCO | SELL | 2006-05-01 | 2006-05-03 | $19.90 | $199K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.